The burden of community-acquired bacterial pneumonia in the era of antibiotic resistance

Expert Review of Respiratory Medicine
Paula PeyraniGlenn S Tillotson

Abstract

Community-acquired pneumonia (CAP) is a significant global health problem and leading cause of death and hospitalization in both the US and abroad. Increasing macrolide resistance among Streptococcus pneumoniae and other pathogens results in a greater disease burden, along with changing demographics and a higher preponderance of comorbid conditions. Areas covered: This review summarizes current data on the clinical and economic burden of CAP, with particular focus on community-acquired bacterial pneumonia (CABP). Incidence, morbidity and mortality, and healthcare costs for the US and other regions of the world are among the topics covered. Major factors that are believed to be contributing to the increased impact of CABP, including antimicrobial resistance, the aging population, and the incidence of comorbidities are discussed, as well as unmet needs in current CABP management. Expert commentary: The clinical and economic burden of CABP is staggering, far-reaching, and expected to increase in the future as new antibiotic resistance mechanisms emerge and the world's population ages. Important measures must be initiated to stabilize and potentially decrease this burden. Urgent needs in CABP management include the development of n...Continue Reading

References

Nov 18, 1995·BMJ : British Medical Journal·M ImpallomeniT R Rogers
Oct 1, 1995·American Journal of Respiratory and Critical Care Medicine·L M MundyR D Moore
May 1, 1993·American Journal of Epidemiology·C JokinenS Soimakallio
Mar 1, 2000·Kansenshōgaku zasshi. The Journal of the Japanese Association for Infectious Diseases·Y KobashiR Soejima
Apr 27, 2001·Kansenshōgaku zasshi. The Journal of the Japanese Association for Infectious Diseases·Y KobashiR Soejima
Aug 24, 2001·Internal Medicine·Y KobashiR Soejima
Aug 13, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·John R LonksAntone A Medeiros
Oct 30, 2003·The Cochrane Database of Systematic Reviews·K DearD Tatham
Jun 25, 2004·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·M CastanheiraH S Sader
Nov 9, 2004·The Journal of Antimicrobial Chemotherapy·Nienke BruinsmaUNKNOWN European Antimicrobial Resistance Surveillance System (EARSS)
Dec 4, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Michael L JacksonLisa A Jackson
Jun 24, 2005·The Journal of Antimicrobial Chemotherapy·Maria-Cristina C BrandileoneJosé-Luis Di Fabio
Oct 21, 2005·The New England Journal of Medicine·Turk Rhen, John A Cidlowski
Dec 8, 2005·JAMA : the Journal of the American Medical Association·Alicia M FryLarry J Anderson
Apr 11, 2006·American Journal of Respiratory and Critical Care Medicine·Mirjam Christ-CrainBeat Müller
Nov 14, 2006·American Journal of Infection Control·Yeong-Hwang ChenChih-Chieh Chou
Nov 23, 2006·The Medical Clinics of North America·Manjunath P PaiKeith A Rodvold
Feb 6, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Lionel A MandellUNKNOWN American Thoracic Society
Mar 3, 2007·American Journal of Respiratory and Critical Care Medicine·Forest W ArnoldUNKNOWN Community-Acquired Pneumonia Organization (CAPO) Investigators
Dec 12, 2007·Antimicrobial Agents and Chemotherapy·Christian G GiskeUNKNOWN ReAct-Action on Antibiotic Resistance
Dec 13, 2007·Journal of Chemotherapy·P B IanniniJ J Schentag
Mar 4, 2008·The Journal of Antimicrobial Chemotherapy·Carl AscheC Daniel Mullins
Mar 29, 2008·American Journal of Respiratory and Critical Care Medicine·Sachin YendeUNKNOWN GenIMS Investigators
Apr 29, 2008·Emerging Infectious Diseases·Caroline L TrotterElizabeth Miller
Jun 7, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Julio RamirezJose Bordon
Nov 28, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Helen W BoucherJohn Bartlett
Oct 14, 2009·Thorax·W S LimUNKNOWN Pneumonia Guidelines Committee of the BTS Standards of Care Committee
Jan 23, 2010·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Miyuki MorozumiKimiko Ubukata
Feb 2, 2010·The Lancet Infectious Diseases·Vicente F Corrales-MedinaDaniel M Musher
Feb 25, 2010·The Journal of Antimicrobial Chemotherapy·James D ChalmersJohn H Winter
Mar 6, 2010·Postgraduate Medicine·Thomas M File, Thomas J Marrie
Jun 19, 2010·International Journal of Antimicrobial Agents·Ronald N JonesHelio S Sader
Jul 10, 2010·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Raul E IsturizJulio Ramirez
Jan 1, 2009·Aging Health·John E StupkaMarcos I Restrepo

❮ Previous
Next ❯

Citations

Dec 17, 2019·Journal of Comparative Effectiveness Research·Victoria DivinoMitch DeKoven
May 15, 2020·The Pediatric Infectious Disease Journal·Ke BaiChangda Li
Sep 29, 2019·JAMA : the Journal of the American Medical Association·Elizabeth AlexanderJennifer Schranz
Nov 28, 2019·Tobacco Induced Diseases·Kgashane Given MatapaCharles Feldman
Jun 11, 2020·The Pediatric Infectious Disease Journal·Ke BaiChangda Li
Jul 25, 2020·Medicine·Hung-Jen TangChih-Cheng Lai
Aug 8, 2020·Frontiers in Microbiology·Freya CoolsPaul Cos
Jan 10, 2021·International Journal of Clinical Practice·Pengxiang ZhouSuodi Zhai
Jan 24, 2021·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Antoni TorresPaul C McGovern
Jan 12, 2021·Critical Care : the Official Journal of the Critical Care Forum·Claire DupuisJean-François Timsit
Mar 5, 2021·American Journal of Infection Control·Richard MooreKari A Mergenhagen
Jun 14, 2021·Infectious Diseases and Therapy·Evdoxia KyriazopoulouEvangelos J Giamarellos-Bourboulis
Jul 10, 2021·Annals of the American Thoracic Society·Charles S Dela CruzRichard G Wunderink

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Related Papers

Current Infectious Disease Reports
Francisco Arancibia, Mauricio Ruiz
Expert Opinion on Pharmacotherapy
Stavros Anevlavis, Demosthenes Bouros
Expert Review of Anti-infective Therapy
Glenn S Tillotson, Stephen H Zinner
© 2021 Meta ULC. All rights reserved